Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry

Spirk, D; Willenberg, T; Aujesky, D; Husmann, M; Hayoz, D; Baldi, T; Brugger, A; Amann-Vesti, B; Baumgartner, I; Kucher, N (2012). Use of biomarkers or echocardiography in pulmonary embolism: the Swiss Venous Thromboembolism Registry. QJM - an international journal of medicine, 105(12), pp. 1163-9. Oxford: Oxford University Press 10.1093/qjmed/hcs144

[img]
Preview
Text
hcs144.pdf - Published Version
Available under License Publisher holds Copyright.

Download (132kB) | Preview

Cardiac biomarkers and echocardiography for assessing right ventricular function are recommended to risk stratify patients with acute non-massive pulmonary embolism (PE), but it remains unclear if these tests are performed systematically in daily practice. Design and methods: Overall, 587 patients with acute non-massive PE from 18 hospitals were enrolled in the Swiss Venous Thromboembolism Registry (SWIVTER): 178 (30%) neither had a biomarker test nor an echocardiographic evaluation, 196 (34%) had a biomarker test only, 47 (8%) had an echocardiogram only and 166 (28%) had both tests.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine > Centre of Competence for General Internal Medicine
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology

UniBE Contributor:

Aujesky, Drahomir and Baumgartner, Iris

ISSN:

1460-2725

Publisher:

Oxford University Press

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:35

Last Modified:

27 Apr 2018 10:04

Publisher DOI:

10.1093/qjmed/hcs144

PubMed ID:

22908319

Web of Science ID:

000312428000004

BORIS DOI:

10.7892/boris.14142

URI:

https://boris.unibe.ch/id/eprint/14142 (FactScience: 220979)

Actions (login required)

Edit item Edit item
Provide Feedback